No Detail Found!

Comparison Between Labetalol and Methyldopa in the Treatment of Pre-eclampsia.

Author(s)
Nosheen Akhtar Department of Obstetrics and Gynaecology, Foundation University Medical College, Fauji Foundation Hospital, Rawalpindi - Pakistan
Zartaj Hayat Department of Obstetrics and Gynaecology, Foundation University Medical College, Fauji Foundation Hospital, Rawalpindi - Pakistan
Fatima Nazim Department of Obstetrics and Gynaecology, Foundation University Medical College, Fauji Foundation Hospital, Rawalpindi - Pakistan
Abstract
Objective: To compare the effects of labetalol and methyldopa on mean diastolic blood pressure in patients with pre-eclampsia. Methodology: A randomized controlled trial was done in the Department of Gynecology and Obstetrics, Fauji Foundation Hospital, Rawalpindi, from 20th August 2013 to 31st march 2014. A total of 300 women with singleton pregnancy (20-37 weeks) diagnosed with pre-eclampsia were randomly assigned to labetalol (n=150) and methyldopa (n=150). The outcome was determined as reduction in mean diastolic blood pressure 48 hours after intervention with labetalol and methyldopa. Results: In labetalol group, the mean age of patients was 32.57 ±4.3 years, while in methyldopa group it was 33.09 ±4.2 years (p value =0.290). In labetalol group, mean diastolic blood pressure was reduced from 100.9 ±6.8 mmHg to 93.5 ±7.2 mmHg (p value =0.000). In methyldopa group, it was reduced from 99.7 ±9.9 mmHg to 93.4 ±7.8 mmHg (p value =0.000). There was no statistical difference in the mean diastolic blood pressure between the two groups after intervention (p value = 0.909). Conclusion: Both labetalol and methyldopa reduced diastolic blood pressure significantly after 48 hours of intervention. The efficacy of both drugs was equal in reducing diastolic blood pressure and the difference was statistically not significant.
Publication Details
Page(s) 35-39
DOI DOI not available
Published Journal: Journal of Postgraduate Medical Institute, Volume: 32, Issue: 1, Year: 2018

Request the full text from PASTIC

References
Rathore R, Butt NF, Iqbal A, Khan MZU. Complications and outcome of patients of pre-eclampsia and eclamp­sia presenting to medical wards of Mayo hospital Lahore. Annals 2010; 16:17-9.
Duley L.,,2009,The global impact of pre-eclampsia and eclampsia,Semin Perinatol,33,130-7
BegumF,ParveenT.,,2008,Antihypertensives in hypertensive disorders of pregnancy,Bangladesh J Obstet Gynaecol,23,65-72
Dekker G.Hypertension,JamesD,SteerPJ,WeinerCP,GonikB,,2010,,High Risk pregnancy management options. London: Saunders;,,599-626
BharathiKN,PrasadKVSRG,,2010,A comparison of nifedipine with Methyldopa for control of blood pressure in mild to moderate pregnancy induced hypertension,J Clin Diagn Res,4,2406-9
MageeLA,AbalosE,von DadelszenP,SibaiB,EasterlingT,WalkinshawS.,,2011,How to manage hypertension in pregnancy effectively,Br J Clin Pharm,72,394-401
PodymowT,AugustP.,,2008,Update on the use of antihypertensive drugs in pregnancy,Hypertension,51,960-9
MolviSN,MirS,RanaVS,JabeenF,MalikAR,,2012,Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa,Arch Gynecol Obstet,285,1553-62
,2009,,Pharmacologyonline,3,670-8
PatelNK,GadhaviM,GorasiaD,PandyaMR,,2012,Comparative evaluation of antihypertensive drugs in the management of pregnancy-induced hypertension,Int J Basic Clin Pharmacol,1,174-7
VermaR,LahonK,TonpaySD,KaleVJ,JainDK,,2012,A comparative randomised controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of new onset hypertension during pregnancy,Int J Life Sci Pharma Res,2,23-31
EkeleBA,,2009,Use of magnesium sulfate to manage pre-eclampsia and eclampsia in Nigeria: overcoming the odds,Ann Afr Med,8,73-5
GuzekDS,KleinVR,TysonJE,LaskyRE,GantNF,rosenfeldCR,,2009,Risk factors for the occurrence of pregnancy induced hypertension,J Clin Exper Hyperten Preg,6,281-97
VenkateswaramurthyN,JohnC,,2012,Study on anti-hypertensive in pre-eclampsia,Asian J Pharm Clin Res,5,126-8
RedmanCWG,GalleryED,MitchellMD,,1984,Fall in BP in response to volume expansion in pregnancy associated hypertension: why does it occur?,Br Med J,2,177-82
PlouinPF,BreartG,MaillardF,PapiernikE,RelierJP,,1988,Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopy in the treatment of hypertension in pregnancy: A randomized controlled trial,Br J Obstet Gynecol,95,868-76
DuleyL,Henderson-SmartDJ,MeherS,,2013,Drugs for treatment of very high blood pressure during pregnancy,Cochrane Database Sys Rev,7,CD001449-
SubhedarV,InamdarS,HariharanC,,2013,Subhedar S. Comparison of efficacy of labetalol and methyldopa in patients with pregnancy induced hypertension,Int J Reprod Contracept Obstet Gynecol,2,27-34
El-QarmalawiAM,MorsyAH,Al-FadlyA,ObeidA,HashemM.,,1995,Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension,Int J Gynaecol Obstet,49,125-30
QasimA,SiddiquiMH,SalamJU,NusratU,,2014,Labetalol versus methyldopa: efficacy in pregnancy induced hypertension,Gomal J Med Sci,12,233-6
SushrutD,Girija,,2013,Labetalol-An emerging first line drug for pregnancy induced hypertension,Indian J Clin Prac,23,640-1
PicklesCJ,SymondsEM,PipkenBF,,1989,The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy induced hypertension,Br J Obstet Gynecol,96,38-43
0

Citations

0

Downloads

91

Views